Prescient Therapeutics Ltd has released a press release.
Offer Document
Filed with ASX ·
On 6ix: 6ix.com/news/offer-document-22
6ix hasn’t read this filing yet.
Prescient Therapeutics Limited on 6ix
Story so far
Earlier from Prescient Therapeutics
- PTX Secures $7.0M Capital Raising
- March 2016 Appendix 4C - Quarterly
- Executive Management Change
- Virax Rights Offer Documentation - 25 May 2011
- VIR201 HIV Vaccine published in AIDS Journal
Later from Prescient Therapeutics
- Replacement Entitlement Offer Prospectus
- Yale Joins PTXs Phase 1b/2 AML Clinical Trial
- June 2016 Appendix 4C - Quarterly
- Change to exercise price of options
- USPTO Grants Allowances for Two PTX-200 Patents
Follow Prescient Therapeutics into a list and get an email when it puts out news.
Follow Prescient Therapeutics